ÐÄÂöÒ½ÁÆ£º2024Äê¶ÈÉç»áÔðÈα¨¸æ

ª¢ª£ª¤ª£ª¥ª¦ª§ª¨ª£ª©ªªª«ª¬ªªª¥ª¬ª­ª«ª®ª¬ª¯ª°ª¤ª±ª£ª¬ªªª¤ª¬ª±ª£ª©ª¤ª¬ª²ªªª«ª®ªªª³ª£ª¯ª£ª²ª´ª¤ª±ª£ª¬ªªª¥ª¬ª¤ª£ª¦ªµª¨ª£ª¬ª±ª®ª¨ª¦ª£ª¶ª£ª±ª¬ª«ª©ªªª«ª®ªªª·ª©ª¬ª¥ªªª¸ª¨ªµª¦ª£ª±ª¬ª¥ªªª«ª®ªªª¶ª¬ª·ª¨ª£ª±ª¬ª¹ªºª©ªªª®ªªª±ª©ª¤ª¦ª¨ª©ª²ª®ªªª«ª®ªªª¸ª¨ª©ª«ª»ª¦ª©ª¥

ª¸ª¬ª¨ª¬ªªª¥ª¬ª­ª«ª®ª¢ª¢ª£ª¤ª¥ª¦ª§ª¨ª©ªªª¤ª§ª£ª«ª£ª«ª§ª¦ª¥ª¬ª£ª¥ª­ª£ª«ª¤ªªª«ª®ª¨ª¦ª«ª¤ª¯ª°ª«ª±ª¯ª²ª³ª´ªµª«ª§ª¨ª«ª´ª¶ª«ª§ª¨ª«ª·ªªª¤ª¨ª¦ª©ª£ª«ª§ª¨ª«ª¸ª±ª±ª±ªµª«ª£ª«ª¹ª¨ªºª©ª¨ª­ª£ª«ª¤ª°ª«ª»ª¯ª¼ª´ª±ªµª«ª§ª¨ª«ª¸ª¶ª§ª¨ª«ªªª½ª©ª¦ª¾ª«ª§ª¨ª«ª¸ª±ª±ª±ª«ª¨ª«ªªª«ª¬ª¿ª½ª¾ª¦ªºªªªÀ ª£ª«ª¤ª£ª«ª¹ª¦!ª©ª¦ª£ª«"#ª¦ªºª¦ªªª¾ª«ª§ªªª«$ª¤ª¦ ª£ª«ª¬ª£ª©ª«%ª¨ª¦ª£ª«ª§ªªª«&ª¨ª¥ª£ª¾ª¿ªÀ ª£ª«&'ª«ª¤(ª«ª»ª¯ª¶ª¸ª»ª¤ªªª«ª§ªªª­ªªª«ª§ª¨ª«ª¼ª²)ª¸ª¸)ª´ª¼ª´ª´ª«ªºª¨ª©ª­ª¦#ª¦ªºª£ª«*ª¿ª¨ª«ªªª«ª¨%ª¬ª©ª¨ª¥ªªªµª«ªªª«ª¥ª¨+ª¿ª¦ª©ª«ª§ª¨ª¥ªºª©ª¦ª­ªªªµª«ªºª¿%ª¬ª©ª¨ª«ªºª£%ª«ªªª«ª¾ª¨+ª¦ª¥ª¾ªªªÀ ª£ª¥ªªª¤ª¦ª­!ª©ª¦ªªª«,ª¦+ª¨ª¤ª­ª¨ªµª«*ª¿ªªª¤ª­ª£ª«-ª¥ª«.ª£ªªª¥ª«/ª©!ª­ª¦ªºªªª¥ª«ª§ª¨ª«0ªªª½ª©ª¦ªºªªªÀ ª£ª«ª§ª¨ª«ª¬ª©ª£ª§ª¿ª­ª£ª¥ª«ª¬ªªª©ªªª«ª¥ªª1ª§ª¨ª«ª¨2ª¦+ª¦ª§ªªª¥ª«ª¬ª¨ª¾ªªªªª¿ª­ª£ª©ª¦ª§ªªª§ª¨ª«ª¥ªªª¤ª¦ª­!ª©ª¦ªªª«ª½ª©ªªª¥ª¦ª¾ª¨ª¦ª©ªªªµª«ª¨ª¥ª­ªªª¤ª§ª£ª«ª¥ª¿ª·ª¨ª¦ª­ªªª«ªªª«ª¦ª¤ª¥ª¬ª¨ªÀ3ª¨ª¥ª«ª¬ª¨ª©ª¦4ª§ª¦ªºªªª¥ª¯ª£ª¤ª¥ª¦ª§ª¨ª¤ª©ªªª«ª¬ª¢ª­ª®ª¤ª©ª¯ª®ª¤ª§ª¢ª°ª§ª¨ª¦ª±ª²ª±ª¦ªªª¢ª³ª©ª´ª±ªµª¤ª¶ª¨ª·ª¸ª¤ª¦ª¢ª°ª«ª´ª¹ª«ª¨ª®ª¢ªºª»ª¦ª±ª·ª¼ª½ª¢ª¾ª±ª¿ªÀª¢ ªªª´ª¿ª¢ª¢ª³ª©ª´ª«ª¦ª«!ª±ª¬ª¢"ª¶ªªª¢ª¤ª©ª´ª¢#ª¦ª´ª¢ª£ª¸ª±ª±ª¦ª¢ª±$ª¢%ª·ª§ª¸ª´ª§ª©ª¯ª¢&#ª¢ª¤ª©ª´ª¢'ª©ª´ª¢ª¤ª©ª´ª¢#ª¦ª´ª¢ª£ª¸ª±ª±ª¦ª¢ª±$ª¢%ª·ª§ª¸ª´ª§ª©ª¯ª¢&(ªÀª¢##)ª¢ª£ª·ª¦ª±ª©ª¯ª®ª·ª¤*ª±ª¤ª´ªÀª¢ª­ª®ª¤ª©ª¯ª®ª¤ª§ªÀª¢'+"#")ªÀª¢ª¾ª®ª§ª©ª¤ª­ª±ª¸ª§ª¨ª§ªªª¤ª©ªªª«ª¬ª¢ª°ª§ª¨ª¦ª±ª²ª±ª¦ªªª¢ª­ª¨ª§ª«ª©ªªª§$ª§ª¨ª¢,ª¤ª¶ª¨ª·ª¸ª¤ª¦ª¢%ª¦ª¤ª¶ª§ª¸ª¢ ªªª´ª¤ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¾-ª².ª¬ª¢'/ª¿")'ª¿+")0+++"1##2ª·ªªª±ª¦ª§3ª¤!4ª±ª¢ª´ª«ª¢ª£ª·ª©ª¨ª§ª±ª©ª¤5ª«ª©ªªª±ª¬ª¢)ª¿"6ª¿67"1+ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª¢ª³8ª¼ª«ª´ª§ª«ª©ªªª«ª¬ª¢'696"9/0''1/ª¾ª«ª¦ªªª§$ª§ª¨ª¤ª´ª±ª¢ª´ª«ª¢%ª±ª¤ª¶ª¢ª²ª¦:ªªª§ª¨ª¤ª¶ª¢ª´ª«ª¢ª£ª¤ª¥ª¦ª§ª¨ª¤!4ª±ª¢ª´ª«ª¢ª²ª¦ª±ª´ª·ªªª±ª¶ª¢ª¼ª¤ª¦ª¤ª¢ª­ª¤;ª´ª«ª¬ª°ª¤ªªª«ª¦ª§ª¤ª§ª¶ª¢ª´ª«ª¢ª·ª¶ª±ª¢5<ª´ª§ª¨ª±ª¢ª´ª¤ª¢ª¨ª¸ª¤ª¶ª¶ª«ª¢=,ª¿5ªªª¾ª¦ª§ªªª§ª¨ª«ªªª­67ª«ª¼ª²)ª¸ª¸)ª´ª¼ª´8>ª±ª¨ª·5ª«ª©ªªª±ª¢ª¤ª¶ª¶ª§ª©ª¤ª´ª±ª¢ª«ª¸ª«ªªª¦ª±ª©ª§ª¨ª¤5ª«ª©ªªª«ª¢ª¼ª±ª¦ª¢ª¬ª¼ª½ªªª±ª½ª¾ª¿ªÀ ª¼ª½ªªª¢ª¿ª¾! ª¾ª½ªªª¢ª½ª¾ ª¼ª¿ªªª¬ª¾ª½"#ª¿ªÀª¯!ª¾!ª¼$!%ª¯!ª¾ª½ªÀªª&!ªªª£ª¼'(!)*ª¿ªª!ªªª¶ '+ª½ªÀ ,ª½)*ª¿ªªª¥ª½ª¼ $-ª¾ ª½ªÀª¢ª«5ª¢+)0""0'+''ªÀª¢?ª¶ª¢"#ª¬"+ªÀª¨ª±ª©$ª±ª¦5ª«ª¢ª®ª±ª¦:ª¦ª§ª±ª¢ª±$ª§ª¨ª§ª¤ª¸ª¢ª´ª«ª¢%ª¦ª¤ª¶@ª¸ª§ª¤ªÀª¢ª¨ª±5ª¢$ª·ª©ª´ª¤5ª«ª©ªªª±ª¢ª©ª±ª¢Aª¢#Bª¢ª´ª±ª¢ª¤ª¦ªªª¿ª¢(Bª¢ª´ª±ª¢>ª«ª¨ª¦ª«ªªª±ª¢ª©B"+ª¿9(#ªÀª¢ª´ª«ª¢"#ª¢ª´ª«ª¢ª©ª±ªµª«5ª¥ª¦ª±ª¢ª´ª«ª¢'+'+ª¢ª®ªªªªª¼ª¬00CCCª¿ª¼ª¸ª¤ª©ª¤ª¸ªªª±ª¿ª¯ª±ªµª¿ª¥ª¦0ª¨ª¨ª§ªµª§ª¸D+#0Dª¤ªªª±'+"/1'+''0'+'+0ª´ª«ª¨ª¦ª«ªªª±0>"+9(#ª¿ª®ªª5ª¿

2ª¢ª¤ª·ªªª«ª©ªªª§ª¨ª§ª´ª¤ª´ª«ª¢ª´ª«ª¶ªªª«ª¢ª´ª±ª¨ª·5ª«ª©ªªª±ª¢ª¼ª±ª´ª«ª¢ª¶ª«ª¦ª¢ª¨ª±ª©$ª«ª¦ª§ª´ª¤ª¢ª©ª±ª¢ª¶ª§ªªª«ª®ªªªªª¼ª¶ª¬00ª¶ª«ª§ª¿ª¤ª©ªµª§ª¶ª¤ª¿ª¯ª±ªµª¿ª¥ª¦0ª¤ª·ªªª«ª©ªªª§ª¨ª§ª´ª¤ª´ª«ªÀª¢ª§ª©$ª±ª¦5ª¤ª©ª´ª±ª¢ª±ª¢ª¨Eª´ª§ª¯ª±ª¢ªµª«ª¦ª§$ª§ª¨ª¤ª´ª±ª¦ª¢./.0102ª¢ª«ª¢ª±ª¢ª¨Eª´ª§ª¯ª±

ª¾*ª¾ª¢3342/254ª¿

Certificado BPF de Produtos para Sa¨²de CAUPS 2129098 SEI 25351.931904/2022-43 / pg. 3

ÉϺ£Î¢´´ÐÄÂöÒ½ÁƿƼ¼£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾ Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. ²É¹º¿ØÖƳÌÐòÖƶȡ¾¹«Ë¾¼¶¡¿ System of Control Procedure of Purchasing¡¾Corporate Level¡¿ Îļþ±àºÅ£ºMPEV/C-PD-001 File Code£ºMPEV/C-PD-001 °æ±¾ºÅ£ºG°æ Rev: G ±àÖÆ£ºÀ¶ Prepared by: Li Chunlu ²¿ÃŸºÔðÈËÉóÅú£º Approval by HOD: ·Ö¹Ü¸±×ܲÃÉóÅú£º Approval by Executive Vice President: ×ܲÃÉóÅú£º Approval by General Director: ÉúЧÈÕÆÚ£º Commencement Date:

1 ÉϺ£Î¢´´ÐÄÂöÒ½ÁƿƼ¼£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾ ¹©·½¹ÜÀíÖƶȡ¾¹«Ë¾¼¶¡¿ Îļþ±àºÅ£ºMPEV/C-PD-002 °æ ±¾ ºÅ£ºI°æ ±à ÖÆ£ºÓÚÔÀÅô ²¿ÃŸºÔðÈËÉóÅú£º ·Ö¹Ü¸±×ܲÃÉóÅú£º ×ܲÃÉóÅú£º ÉúЧÈÕÆÚ£º

TBEV-7.1-0012

Shangai Microport Endovascular (Group) MedtechCo.,Ltd

°æȨËùÓУ¬Î´¾­ÔÊÐí²»µÃ¸´ÖÆ£¡No reproduction or networking permitted withoutlicense from Endovastec!

ÉϺ£Î¢´´ÐÄÂöÒ½ÁƿƼ¼£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾

µÚ1Ò³£¬¹²2Ò³ Page 1 of 2

°æ±¾£ºB

¹©·½ÉóºË±¨¸æSupplier Audit ReportNO£º

ÆóÒµÃû³ÆSupplier name

ÉóºËµØÖ·Audit addressÉóºËÈÕÆÚAudit date²úÆ·¹¤ÐòProduct processÉæ¼°²úÆ·ProductÉóºËÄ¿µÄAudit objectiveÏÖ³¡ÉóºËÇé¿öOn-site audit summary£º

ÒÔ³µ¼äÏÖ³¡¼ì²éºÍÎļþ¼ì²éÏà½áºÏµÄ·½Ê½£¬¶Ô¡Á¡Á¡Á¹«Ë¾µÄ¡Á¡Á¡ÁÏà¹ØÌåϵ¹ý³Ì½øÐÐÉóºË£¬½á¹û»ã×ÜÈçÏ£º

The process of ¡Á¡Á¡Á related system of ¡Á¡Á¡Á Company was audited by combining on-

site workshop

inspection and document inspection, and the results were summarized as follows:

ÐòºÅ

site workshop
		NO.

ÐÔÖÊ

ÉóºË·¢ÏÖ

Nature

Findings

Ìõ¿î

1 ²»ºÏ¸ñÏî

2 ¹Û²ìÏî

3 ¡¤¡¤¡¤¡¤¡¤¡¤

×ÛÉÏËùÊö£¬±¾´ÎÉóºË¹²ÓСÁ¡Á¡ÁÉóºË·¢ÏÖ¡£×Ô±¨¸æË«·½È·ÈϺó£¬ÇëÔÚ1¸öÔÂÄÚÖƶ¨Õû¸Ä¼Æ»®£¬²¢Ôڼƻ®Ê±¼äÄÚÍê³ÉÕû¸Ä¡£

To sum up, there are ¡Á¡Á¡Á audit findings in this audit.

Clause

After the confirmation of both parties in the report,

the corrective action plan shall be made within 1 month and the corrective action shall be completed withinthe planned time.

TBEV-7.1-0012

After the confirmation of both parties in the report,

ÉϺ£Î¢´´ÐÄÂöÒ½ÁƿƼ¼£¨¼¯ÍÅ£©¹É·ÝÓÐÏÞ¹«Ë¾Shangai Microport Endovascular (Group) MedtechCo.,Ltd°æȨËùÓУ¬Î´¾­ÔÊÐí²»µÃ¸´ÖÆ£¡No reproduction or networking permitted withoutlicense from Endovastec!

ÉóºË×é³ÉÔ±Audit team Signature

Ç©×Ö£º ʱ¼ä£º

¹©Ó¦ÉÌÈ·ÈÏSupplier confirmation

Ç©×Ö£º ʱ¼ä£º